3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Multiple Myeloma
25
Breast Neoplasms
21
Colorectal Neoplasms
17
Neoplasms
16
Prostatic Neoplasms
15
Lymphoma, B-Cell
15
Stomach Neoplasms
13
Carcinoma, Hepatocellular
12
Recurrence
11
Pancreatic Neoplasms
11
Lung Neoplasms
11
Leukemia, Myeloid, Acute
11
Carcinoma, Non-Small-Cell Lung
11
Burkitt Lymphoma
11
Solid Tumor
10
Uterine Cervical Neoplasms
9
Lymphoma, Non-Hodgkin
9
Glioblastoma
9
Leukemia
8
Ovarian Neoplasms
7
Glioma
7
Sarcoma
6
Polycystic Ovary Syndrome
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma
5
Hematologic Neoplasms
5
Head and Neck Neoplasms
5
Neuroendocrine Tumors
4
Lymphoma, T-Cell, Peripheral
4
Interventions
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Unknown
×
Osteopetrosis, Autosomal Recessive 7
×
Clear all
NCT03691311
2021-11-03
D-BIOMARK
Institut Català d'Oncologia
Phase EARLY_PHASE1
Unknown
60 enrolled